CMR International was created in 1981 as a division of the Association of the British Pharmaceutical Industry (ABPI). CMR International's initial role was to challenge public policy and regulatory issues that could adversely affect drug development. Early success, for example in amending long-term study requirements, placed CMR International at the center of pharmaceutical analysis and reform.